ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $591M

      Shares

      15.8M

      % of Portfolio

      0.75%

      Average Buy Price

      $20.8

      Avg closing price
      Price range

      43 Jim Simons Exelixis Trades

      Jim Simons's position in Exelixis is currently worth $591M. That's 0.75% of their equity portfolio (15th largest holding). The investor owns 5.87% of the outstanding Exelixis stock. The first Exelixis trade was made in Q2 2014. Since then Jim Simons bought shares 24 more times and sold shares on eighteen occasions. The stake costed the investor $329M, netting the investor a gain of 80% so far.

      Avg closing price
      Price range
      Increased shares by 6.7% (+996k shares) Q2 2025
      Avg closing price $39.97
      Price range $34.13 - $46.26
      Sold 3.1% shares (-472k shares) Q1 2025
      Avg closing price $35.61
      Price range $32.38 - $39.16
      Sold 0.4% shares (-64.1k shares) Q4 2024
      Avg closing price $32.52
      Price range $25.39 - $36.46
      Increased shares by 1.3% (+197k shares) Q3 2024
      Avg closing price $24.83
      Price range $21.96 - $27.60
      Increased shares by 0.4% (+61.4k shares) Q2 2024
      Avg closing price $22.19
      Price range $20.34 - $23.73
      Sold 3.3% shares (-514k shares) Q1 2024
      Avg closing price $22.23
      Price range $20.17 - $23.93
      Increased shares by 2.6% (+399k shares) Q4 2023
      Avg closing price $21.74
      Price range $19.25 - $24.13
      Increased shares by 3.9% (+569k shares) Q3 2023
      Avg closing price $20.92
      Price range $19.04 - $22.74
      Sold 4.1% shares (-632k shares) Q2 2023
      Avg closing price $19.27
      Price range $18.17 - $20.48
      Increased shares by 2.1% (+318k shares) Q1 2023
      Avg closing price $17.42
      Price range $16.30 - $19.41
      Sold 6.7% shares (-1.07M shares) Q4 2022
      Avg closing price $16.31
      Price range $14.96 - $17.39
      Sold 9.9% shares (-1.75M shares) Q3 2022
      Avg closing price $19.32
      Price range $15.68 - $22.27
      Increased shares by 5.5% (+922k shares) Q2 2022
      Avg closing price $20.61
      Price range $17.44 - $23.16
      Sold 1.4% shares (-239k shares) Q1 2022
      Avg closing price $19.53
      Price range $17.03 - $22.67
      Sold 2.5% shares (-447k shares) Q4 2021
      Avg closing price $19.14
      Price range $15.84 - $21.88
      Sold 3.0% shares (-535k shares) Q3 2021
      Avg closing price $18.57
      Price range $16.30 - $21.14
      Sold 3.0% shares (-550k shares) Q2 2021
      Avg closing price $23.32
      Price range $17.95 - $25.56
      Sold 14.1% shares (-3.05M shares) Q1 2021
      Avg closing price $22.58
      Price range $20.53 - $25.22
      Sold 4.3% shares (-983k shares) Q4 2020
      Avg closing price $20.93
      Price range $18.39 - $24.80
      Sold 1.5% shares (-341k shares) Q3 2020
      Avg closing price $23.34
      Price range $20.67 - $26.94

      News about Exelixis Inc and Jim Simons

      Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?

      Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?

      Novo Nordisk and Exelixis are favorites of billionaire Jim Simons' hedge fund. Novo Nordisk has a deep lineup and pipeline and expertise in diabetes and obes...

      fool.com fool.com, over 1 year ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×